Moderna Inc. buy UBS Group AG
Start price
26.06.23
/
50%
€111.22
Target price
26.06.24
€174.90
Performance (%)
2.48%
End price
27.06.24
€113.98
Summary
This prediction ended on 27.06.24 with a price of €113.98. With a performance of 2.48%, the BUY prediction by UBS_Group_AG for Moderna Inc. closed with a slight gain. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 5.965% | 5.965% | 51.331% |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $191.00 price target on the stock, down previously from $221.00.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten